Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does HYALURONIDASE Cause Therapy non-responder? 110 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 110 reports of Therapy non-responder have been filed in association with HYALURONIDASE (Phesgo). This represents 9.9% of all adverse event reports for HYALURONIDASE.

110
Reports of Therapy non-responder with HYALURONIDASE
9.9%
of all HYALURONIDASE reports
97
Deaths
106
Hospitalizations

How Dangerous Is Therapy non-responder From HYALURONIDASE?

Of the 110 reports, 97 (88.2%) resulted in death, 106 (96.4%) required hospitalization, and 108 (98.2%) were considered life-threatening.

Is Therapy non-responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HYALURONIDASE. However, 110 reports have been filed with the FAERS database.

What Other Side Effects Does HYALURONIDASE Cause?

Fatigue (375) Alopecia (358) Abdominal discomfort (355) Arthralgia (349) Diarrhoea (330) Headache (328) Hypertension (325) Blood cholesterol increased (320) Arthropathy (318) Off label use (315)

What Other Drugs Cause Therapy non-responder?

ETANERCEPT (3,472) APREMILAST (3,360) METHOTREXATE (2,965) RITUXIMAB (2,731) ADALIMUMAB (2,595) PREDNISONE (2,563) TREPROSTINIL (2,289) INFLIXIMAB (2,122) TOCILIZUMAB (1,775) HYDROXYCHLOROQUINE (1,699)

Which HYALURONIDASE Alternatives Have Lower Therapy non-responder Risk?

HYALURONIDASE vs HYALURONIDASE-OCSQ\OCRELIZUMAB HYALURONIDASE vs HYALURONIDASE \RITUXIMAB HYALURONIDASE vs HYALURONIDASE-ZZXF\PERTUZUMAB\TRASTUZUMAB HYALURONIDASE vs HYDRALAZINE HYALURONIDASE vs HYDRALAZINE\ISOSORBIDE DINITRATE

Related Pages

HYALURONIDASE Full Profile All Therapy non-responder Reports All Drugs Causing Therapy non-responder HYALURONIDASE Demographics